NEURONED-MS. Multiple Sclerosis in the Netherlands. A prospective inception cohort study.

NEURONED-MS. Multiple Sclerosis in the Netherlands. A prospective inception cohort study. - NEURONED-MS. A prospective inception cohort study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41541

Enrollment

300

Registered

2011-10-07

Start date

2012-03-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MS multiple sclerosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients are eligible when they are diagnosed within the previous twelve months with MS (Polman et al., 2011), with dissemination in time and space (see protocol Appendix 3). Patients with Clinically Isolated Syndromes (CIS) may also be included if they fulfill 3 of the 4 Barkhof criteria for dissemination in space as per application of the revised McDonald criteria (Polman et al. 2011). Patients should be 18 years or older, and live in the Netherlands, and give written informed consent.

Exclusion criteria

Exclusion criteria: not able to speak dutch, refusal to give informed consent

Design outcomes

Primary

Measure	Time frame
Clinical and psychosocial data of all patients will be collected longitudinally and prospectively on a regular basis.	—

Countries

Netherlands

Outcome results